We also previously demonstrated significantly increased CRP serum concentrations in cases of tumor recurrence, that high CRP serum levels predict worse FFR, and that CRP is a significant predictive marker for detection of tumor recurrence (p = 0.037; R2: 0.147).7 The predictive power was increased when CRP was used in combination with Fibrinogen (R2: 0.825), NLR (R2: 1.000), or PLR (R2: 0.726); however, the significance of each marker for predicting tumor recurrence was lost (Fibrinogen p = 0.352 and CRP p = 0.112; NLR p = 0.994 and CRP p = 0.991; PLR p = 0.726 and CRP p = 0.056). Here, CRP is linked to neoplasm.